EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing ADHD prevalence and comorbidities in the United States: Insights from the Substance Abuse and Mental Health Services (SAMHSA) data

Mahie Patil, Sanjana Konda, Latha Ganti

Cambridge Prisms: Global Mental Health · 2024 · 11

DOI: 10.1017/gmh.2024.104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cambridge Prisms: Global Mental Health, online erschienen am 06.12.2024. Verfasst von Mahie Patil und 2 weiteren Autor:innen. Beteiligte Einrichtung: Orlando Science School, University of Central Florida, Orlando, FL, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study analyzes 2022 data from SAMHSA’s Mental Health Client-Level Data (MH-CLD) to investigate ADHD prevalence and comorbidity. The findings reveal that 10.70% of the 5,899,698 patients were diagnosed with ADHD, indicating a high demand for targeted resources. ADHD prevalence declines with age, highest in children aged 0–11, and decreases with educational attainment, emphasizing the need for early intervention. Employment challenges are significant, with the highest ADHD prevalence among those not in the labor force. Racial disparities show Black individuals have the highest ADHD rates (9.71%) and Asian individuals the lowest (5.05%). Geographic differences indicate higher prevalence in the Midwest and South. Gender disparities and marital status also influence prevalence, with males and never-married individuals showing higher rates. ADHD shows strong comorbidity with oppositional defiant disorder, pervasive developmental disorder/autism spectrum disorder and conduct disorder. Effective ADHD management requires collaborative efforts from educators, employers, healthcare providers and policymakers to create supportive environments and tailored approaches considering demographic variables, comorbid conditions and socioeconomic factors.

Schlagwörter

Stichwörter der Autor:innen

ADHD comorbiditiesADHD demographicsADHD hospitalizationAttention deficit hyperactivity disorderSubstance Abuse and Mental Health Services Administration

Autor:innen und Institutionen

  • Orlando Science School, University of Central Florida, Orlando, FL, USA.
  • The Warren Alpert Medical School of Brown University, Providence, RI, USA.
  • Orlando College of Osteopathic Medicine, Winter Garden, FL, USA.

Zitieren

APA

Patil, M., Konda, S., & Ganti, L. (2024). Assessing ADHD prevalence and comorbidities in the United States: Insights from the Substance Abuse and Mental Health Services (SAMHSA) data. Cambridge Prisms: Global Mental Health, 11. https://doi.org/10.1017/gmh.2024.104

Vancouver

Patil M, Konda S, Ganti L. Assessing ADHD prevalence and comorbidities in the United States: Insights from the Substance Abuse and Mental Health Services (SAMHSA) data. Cambridge Prisms: Global Mental Health. 2024;11. doi:10.1017/gmh.2024.104

BibTeX
@article{Patil2024,
  author = {Patil, Mahie and Konda, Sanjana and Ganti, Latha},
  title = {Assessing ADHD prevalence and comorbidities in the United States: Insights from the Substance Abuse and Mental Health Services (SAMHSA) data},
  journal = {Cambridge Prisms: Global Mental Health},
  year = {2024},
  volume = {11},
  doi = {10.1017/gmh.2024.104}
}
Kostenlos starten →